Share on StockTwits

Merck & Co. (NYSE:MRK) shares reached a new 52-week high on Monday , ARN reports. The company traded as high as $59.87 and last traded at $59.79, with a volume of 2,230,069 shares changing hands. The stock had previously closed at $59.17.

A number of analysts have recently weighed in on MRK shares. Analysts at Zacks reiterated a “neutral” rating on shares of Merck & Co. in a research note on Monday, August 18th. They now have a $62.00 price target on the stock. Separately, analysts at Jefferies Group cut their price target on shares of Merck & Co. from $63.00 to $60.00 in a research note on Monday, August 11th. They now have a “hold” rating on the stock. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Merck & Co. in a research note on Thursday, July 31st. They now have a $59.00 price target on the stock, up previously from $56.00. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $60.64.

The stock has a 50-day moving average of $57.89 and a 200-day moving average of $57.00. The company has a market cap of $172.4 billion and a price-to-earnings ratio of 31.17.

Merck & Co. (NYSE:MRK) last announced its earnings results on Tuesday, July 29th. The company reported $0.85 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.80 by $0.05. The company had revenue of $10.93 billion for the quarter, compared to the consensus estimate of $10.60 billion. During the same quarter last year, the company posted $0.84 earnings per share. Merck & Co.’s revenue was down .7% compared to the same quarter last year. On average, analysts predict that Merck & Co. will post $3.49 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, October 7th. Stockholders of record on Monday, September 15th will be given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.97%. The ex-dividend date of this dividend is Thursday, September 11th.

In other Merck & Co. news, CEO Kenneth C. Frazier sold 10,058 shares of the stock on the open market in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $57.00, for a total value of $573,306.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Merck & Co, Inc (NYSE:MRK), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures.

Receive News & Ratings for Merck & Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck & Co Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.